Pay in 4 interest-free payments of $6.10 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
28 In the phase 3 BWEL study (NCT02750826), which also tested telephone-based weight loss counseling, participants had a mean weight loss of 4.8% at 12 months
Obesity Treatment With Bariatric Surgery vs GLP-1 Receptor Agonists
Financial Highlights Gland Pharma demonstrated robust performance in the second quarter, with revenue climbing to 1,487.00 crore, marking a 5.80% increase from 1,406.00 crore in the same period last year
The revised Cochrane risk-of-bias tool for the nonrandomized trial I ( ROBINS-I ) was used for nonrandomized studies
US$ 24.15
US$ 21.02
US$ 24.12
US$ 20.36
US$ 21.09
